Deep 6 AI

By Tempus AI (formerly Deep 6 AI)
· USA
Tempus AI — AI-assisted clinical trial patient matching.
RAG / Knowledge AI
Oncology
Production
Not Formally Regulated
Regulatory status
Not Formally Regulated
Deployment
Production
Clinical role
Adjunct (decision support)
Headquarters
USA
AI type
RAG / Knowledge AI

Precise indication

AI-assisted clinical trial patient matching.

Regulatory status

Not applicable — a trial-matching tool, not a diagnostic device.

Clinical evidence

Vendor-supported

Acquirer’s (Tempus AI) own press release confirming the acquisition.

Independent

Not found in this research pass — verify before publishing.

Real-world deployment

Used by life-science teams according to industry sources; no hospital-level deployment figure found.

Interoperability

European status

Editorial verdict

Limits and uncertainties

Borderline fit for a clinical-diagnostic-AI catalogue — confirm with Mohammed whether trial-matching tools belong in scope.

Sources

https://www.tempus.com/news/pr/tempus-announces-acquisition-of-deep-6-ai/

This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate

At a glance
Vendor
Tempus AI (formerly Deep 6 AI)
Headquarters
USA
AI type
RAG / Knowledge AI
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate

Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.

A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.

Read the methodology →

Spotted an error?

Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.